Literature DB >> 11011963

First experience with gamma probe guided sentinel lymph node surgery in penile cancer.

F Wawroschek1, H Vogt, D Bachter, D Weckermann, M Hamm, R Harzmann.   

Abstract

Because of the curative approach, the detection of lymph node metastases in squamous cell carcinoma (SCC) of the penis is of significant clinical relevance. Sentinel lymph node (SLN) identification by means of lymphangiography has been proven to be insufficiently safe. However, the high morbidity of inguinal lymphadenectomy and the considerable individual variability regarding the location of lymph node metastases justify the necessity of a technique that enables the identification of SLNs. Since 1998, SLNs have been intraoperatively identified and selectively dissected, after peritumoral injection of technetium-99m nanocolloid and using lymphoscintigraphy, in three patients (one with malignant melanoma and two with SCC). At least one SLN could be detected in each patient. The maximum surgical time was 30 min. There were no severe complications. Lymph node metastases did not occur in any patient. Upon a mean follow-up of 10 months, all patients are currently free of tumor. Owing to the long-term results of sentinel lymphadenectomy in malignant melanoma of other locations and our preliminary results with respect to penile carcinoma. we consider the current method appropriate as the only primary operation for lymph node staging in early stages and, in combination with modified inguinal lymphadenectomy, in locally advanced stages.

Entities:  

Mesh:

Year:  2000        PMID: 11011963     DOI: 10.1007/s002400000125

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  12 in total

1.  Prostate lymphoscintigraphy for sentinel lymph node identification in canines: reproducibility, uptake, and biokinetics depending on different injection strategies.

Authors:  Friedhelm Wawroschek; Hermann Wengenmair; Reingard Senekowitsch-Schmidtke; Michael Hamm; Julia Henke; Tanja Schönberger; Andrea Hauser; Wolf Erhardt; Rolf Harzmann
Journal:  Urol Res       Date:  2003-03-25

2.  Lymphoscintigraphy in penile cancer: limited value of sentinel node biopsy in patients with clinically suspicious lymph nodes.

Authors:  E Hungerhuber; B Schlenker; D Frimberger; R Linke; A Karl; C G Stief; P Schneede
Journal:  World J Urol       Date:  2006-04-11       Impact factor: 4.226

Review 3.  Sentinel node biopsy and lymphatic mapping in penile and prostate cancer.

Authors:  H G van der Poel; P Meershoek; N Grivas; G KleinJan; F W B van Leeuwen; S Horenblas
Journal:  Urologe A       Date:  2017-01       Impact factor: 0.639

Review 4.  [Lymph node management of cN0 penile cancer].

Authors:  F Wawroschek; A Winter
Journal:  Urologe A       Date:  2018-04       Impact factor: 0.639

Review 5.  [Value of sentinel node biopsy for urological tumors].

Authors:  F Wawroschek; R Harzmann; D Weckermann
Journal:  Urologe A       Date:  2005-06       Impact factor: 0.639

Review 6.  A comprehensive overview of radioguided surgery using gamma detection probe technology.

Authors:  Stephen P Povoski; Ryan L Neff; Cathy M Mojzisik; David M O'Malley; George H Hinkle; Nathan C Hall; Douglas A Murrey; Michael V Knopp; Edward W Martin
Journal:  World J Surg Oncol       Date:  2009-01-27       Impact factor: 2.754

Review 7.  Current trends in the management of carcinoma penis--a review.

Authors:  Iqbal Singh; A Khaitan
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

8.  Fluorescence diagnosis: a novel method to guide radical inguinal lymph node dissection in penile cancer.

Authors:  D Frimberger; R Linke; H Meissner; H Stepp; D Zaak; E Hungerhuber; R Waidelich; N Schmeller; A Hofstetter; P Schneede
Journal:  World J Urol       Date:  2003-08-27       Impact factor: 4.226

9.  Radioguided surgery in urological malignancies.

Authors:  Dorothea Weckermann; Mark Thalgott; Gabriele Holl; Theodor Wagner; Rolf Harzmann
Journal:  Indian J Urol       Date:  2008-01

10.  Reliability of radioisotope-guided sentinel lymph node biopsy in penile cancer: verification in consideration of the European guidelines.

Authors:  Tim Schubert; Jens Uphoff; Rolf-Peter Henke; Friedhelm Wawroschek; Alexander Winter
Journal:  BMC Urol       Date:  2015-09-28       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.